SUBSTANTIAL EXTERNAL DOSE RATE VARIABILITY OBSERVED IN A COHORT OF LU-177 PATIENTS INDEPENDENT OF BMI AND SEX
Author:
Affiliation:
1. Department of Medical Physics, Memorial Sloan Kettering , 1275 York Avenue, New York, NY 10065 , USA
2. Siena College , 515 Loudon Road, Loudonville, New York, NY 12211 , USA
Abstract
Funder
National Institutes of Health
National Cancer Institute Cancer Center
Publisher
Oxford University Press (OUP)
Subject
Public Health, Environmental and Occupational Health,Radiology, Nuclear Medicine and imaging,General Medicine,Radiation,Radiological and Ultrasound Technology
Link
https://academic.oup.com/rpd/article-pdf/198/19/1476/47069367/ncac187.pdf
Reference27 articles.
1. Manual on the proper use of lutetium-177-labeled somatostatin analogue (Lu-177-DOTA-TATE) injectable in radionuclide therapy;Hosono;Ann. Nucl. Med.,2018
2. Therapeutic radiopharmaceuticals;Volkert;Chem. Rev.,1999
3. Phase I-II study of radiopeptide 177Lu-octreotate in combination with capecitabine and temozolomide in advanced low-grade neuroendocrine tumors;Claringbold;Cancer Biother. Radiopharm.,2012
4. The 2007 Recommendations of the International Commission on Radiological Protection. ICRP Publication 103;ICRP
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Monte Carlo simulations for targeted beta therapy: An optimization for liver lesions and comparison of dose distributions in other organs;Radiation Medicine and Protection;2023-12
2. Radiation exposure assessment of nuclear medicine staff administering [177Lu]Lu-DOTA-TATE with active and passive dosimetry;EJNMMI Physics;2023-11-14
3. Radiation Exposure Assessment of Nuclear Medicine Staff Administering [177Lu]Lu-DOTA-TATE with Active and Passive Dosimetry;2023-07-13
4. Contact restriction time after common nuclear medicine therapies: spreadsheet implementation based on conservative retention function and individual measurements;Journal of Radiological Protection;2023-04-19
5. What have we learnt from the past – would treatment decisions for GEP-NET patients differ between 2012 to 2016 by the new recommendations in 2022?;BMC Cancer;2023-02-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3